About Guardiome
Guardiome is a company based in San Diego (United States) founded in 2015 by Huwate Yeerna. It operates as a D2C and B2C. Guardiome offers products and services including Genome Sequencing Service, Genome Report, and Genome Explorer App. Guardiome operates in a competitive market with competitors including 23andMe, Helix, Counsyl, DDC Paternity Tests and Arivale, among others.
- Headquarter San Diego, United States
- Founders Huwate Yeerna
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$5.8 M (USD)10.32as on Mar 31, 2023
-
Net Profit
$661.79 K (USD)-5.82as on Mar 31, 2023
-
EBITDA
$5.02 M (USD)9.54as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Guardiome
Guardiome offers a comprehensive portfolio of products and services, including Genome Sequencing Service, Genome Report, and Genome Explorer App.
Offers full genome sequencing with secure data delivery and privacy.
Provides in-depth reports on impactful genetic variants and consequences.
Enables users to search and analyze personal genome data via app.
Funding Insights of Guardiome
Detailed funding history for Guardiome
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Guardiome
Investment portfolio details for Guardiome
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Guardiome
Detailed financials for Guardiome
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Guardiome Comparisons
Peer comparison for Guardiome
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Guardiome
Guardiome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 23andMe, Helix, Counsyl, DDC Paternity Tests and Arivale, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
|
|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
|
|
| Locked | Locked | Locked |
DNA tests and personalized diagnostics are provided for various specialties.
|
|
| Locked | Locked | Locked |
Provider of direct-to-consumer genetic testing.
|
|
| Locked | Locked | Locked |
Personalized healthcare is delivered through DNA and gut biome testing.
|
Detailed competitors of Guardiome
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Guardiome
Complete news archive for Guardiome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Guardiome
Guardiome was founded in 2015.
Guardiome is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Huwate Yeerna is the current CEO of Guardiome. They have also founded this company.
Annual revenue of Guardiome is $5.8M as on Mar 31, 2023.
Guardiome, founded in 2015, specializes in private genome sequencing services with a focus on data privacy. Customers order kits online, submit samples, and receive secure genome files and reports after processing entirely on American soil. The company uses FDA-benchmarked bioinformatics for high-quality analysis and does not retain customer data, serving individuals through direct ordering or via physicians for health insights.
Guardiome's top competitors include 23andMe, Helix and DDC Paternity Tests.
Guardiome offers Genome Sequencing Service, Genome Report, and Genome Explorer App.